RAPT Therapeutics, Inc.RAPTNASDAQ

Revenue (LTM)

Net Income (LTM)

$-130M

-11.2% YoY

Free Cash Flow

$-83M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	5	4↓24.4%	2↓60.0%	0	0
Gross Profit	5	4↓24.4%	2↓60.0%	0	0
Operating Income	-53	-69↓30.1%	-86↓24.0%	-127↓48.1%	-136↓7.1%
Net Income	-53	-69↓30.8%	-84↓21.1%	-117↓39.3%	-130↓11.2%
EBITDA	-52	-68↓30.9%	-85↓24.2%	-126↓48.5%	-135↓7.2%
EPS Diluted	-17.53	-20.21↓15.3%	-20.61↓2.0%	-24.37↓18.2%	-25.49↓4.6%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	25	24↓3.6%	39↑62.1%	47↑21.9%	170↑257.5%
Total Current Assets	116	193↑66.9%	253↑30.9%	162↓36.0%	235↑45.4%
Total Assets	119	199↑67.0%	266↑34.0%	173↓34.9%	240↑38.7%
Total Current Liabilities	12	10↓18.3%	14↑48.2%	22↑53.5%	48↑121.4%
Total Liabilities	15	12↓17.1%	21↑71.7%	26↑25.0%	50↑91.8%
Total Equity	104	186↑78.9%	245↑31.5%	147↓40.0%	190↑29.2%
Total Debt	0	0	9	7↓23.2%	4↓35.0%
Net Debt	-25	-24↑3.6%	-30↓24.7%	-41↓35.4%	-165↓307.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-40	-61↓50.7%	-71↓16.0%	-97↓37.1%	-83↑14.2%
Capital Expenditure	-0	-1↓89.7%	-1↓11.9%	-1↓33.1%	-0↑89.2%
Free Cash Flow	-41	-62↓51.1%	-72↓15.9%	-98↓37.1%	-83↑15.0%
Stock-Based Comp	9	10↑14.6%	11↑13.2%	0	20
Net Change in Cash	-52	-1↑98.3%	15↑1774.4%	9↓42.8%	122↑1332.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance